All You Need to Know About Oric Pharmaceuticals (ORIC) Rating Upgrade to Buy

• click to rate

  Posted by Two Blokes Jun 19 - Filed in Stock - 1 view
  
  Oric Pharmaceuticals (ORIC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.